Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
about
TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet contentGenetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to managementThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundThe Immune Landscape in Nonalcoholic Steatohepatitis.Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of playBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeGene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewTM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver DiseaseNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistanceGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisInsights into blood lipids from rare variant discoveryDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewMolecular Pathogenesis of NASHHow Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Recent advances in understanding/management of non-alcoholic steatohepatitis.Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseTransmembrane 6 superfamily 1 (Tm6sf1) is a novel lysosomal transmembrane proteinMetabolism Disrupting Chemicals and Metabolic DisordersThe genetic architecture of type 2 diabetesSystematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patientsGenetic predisposition in nonalcoholic fatty liver disease.Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.Susceptibility to human cancer: From the perspective of a pathologist.Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis.Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.Improved ancestry estimation for both genotyping and sequencing data using projection procrustes analysis and genotype imputation.Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease.Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Non-alcoholic fatty liver disease: An expanded reviewThe Association between Pediatric NAFLD and Common Genetic Variants.MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.Identification of the gene that codes for the σ2 receptor.No large-effect low-frequency coding variation found for myocardial infarctionInactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic diseaseTM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
P2860
Q24299190-20FE38BE-7BD2-4EF1-B9D2-025BC82EB2C4Q26741557-991574D3-21CF-48BE-A5A4-AD5AC69F87C9Q26744380-2CB3583B-8FA4-40D3-BE0B-678ED3D7CE4CQ26747323-3FAA6A23-6D78-45C5-8F36-7762A1A329CFQ26764911-42536C63-9A84-4512-BE70-6B0F49EF1519Q26765455-552548E0-3591-4C95-B816-2202B8050016Q26766459-CD18660A-C1BE-401E-8F89-7A2CC979791DQ26774883-149CEEA1-1C00-4E93-BE44-33234A0CAE34Q26778135-46468FBD-8413-4D91-864D-1EB00639AAAFQ26780248-2ECC046D-0FFF-48E3-BBCC-79E3CCB7B878Q26798151-B7FE9929-A737-4246-A7F5-AAD8C1B41135Q26798155-BC427ED0-AEF0-4300-B967-2EBB71A40626Q26799138-0F2869CF-4585-4158-9DA8-B79477BE623FQ28070408-5ED8435A-916E-498D-BCFB-8C7FD687F31DQ28071265-84C09D57-B9F2-4C55-9107-0D5EB9FCE1B6Q28074455-FFDFCC07-47A5-40C5-AADC-C046A512349DQ28085689-B5052D1F-D823-41BB-BECB-CF0F3D0A11DAQ28551941-2F86710A-A829-44EA-A2BB-F757DC48E356Q28593295-81D86619-1554-4B92-9D17-4F4F361F2F15Q29248099-7F5B0A73-77D8-475B-8339-ECA97C736130Q29583824-E25CD6DD-559D-4750-A3BC-BE76E7991996Q29994538-860B149A-7391-40E2-A387-080E1038F623Q30235398-BAF4B37E-811E-4937-B268-236C98182D43Q30241654-4F7B83A8-BFED-4917-8CAE-E26BD1FF71D4Q30250217-BF3F585E-8D2A-41FF-AA88-88FB01808C12Q30373501-2FD4A414-5782-486B-BD8B-78ED02E96C5CQ30382278-30F372A6-F51D-4EA0-B870-69110A7F214CQ30732041-4163B66C-6240-4485-9921-57B82287FBA7Q30961835-2D8C12C6-F82A-4EF8-BD88-390C5BD32208Q33360950-F04A0D67-0F05-4F46-8502-61DC0E7B5EF9Q33618518-9082010A-959D-432D-A764-1207696751C5Q33778556-D651FB66-B3BC-4005-A1CE-4E4E06380A25Q33789868-7326E08A-67FE-45A6-AF6C-9E62B776AFF9Q33831722-C6BEE133-8E06-4E6D-917A-BB4F8E6733DDQ33866766-78F05F2F-8FA6-4DA5-BDB9-B8706633B7BBQ33887088-66453101-7C9B-48DB-9445-05F5A508DD11Q33991765-BD2048FF-D0E2-4F7B-9C8B-363F6C11C85FQ34519771-5418AEFC-8758-45C1-961A-8BD9131C60E9Q34677873-B0B74C4A-C3A0-48E6-B36D-F66F1879CF29Q34785862-7F54707A-E254-4D70-9810-94235CA1473B
P2860
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exome-wide association study i ...... alcoholic fatty liver disease.
@ast
Exome-wide association study i ...... alcoholic fatty liver disease.
@en
Exome-wide association study i ...... alcoholic fatty liver disease.
@nl
type
label
Exome-wide association study i ...... alcoholic fatty liver disease.
@ast
Exome-wide association study i ...... alcoholic fatty liver disease.
@en
Exome-wide association study i ...... alcoholic fatty liver disease.
@nl
prefLabel
Exome-wide association study i ...... alcoholic fatty liver disease.
@ast
Exome-wide association study i ...... alcoholic fatty liver disease.
@en
Exome-wide association study i ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Exome-wide association study i ...... alcoholic fatty liver disease.
@en
P2093
Eriks Smagris
Heather H Zhou
Helen H Hobbs
Jonathan C Cohen
Julia Kozlitina
Thomas F Vogt
P2860
P2888
P304
P356
10.1038/NG.2901
P407
P577
2014-02-16T00:00:00Z